Innoviva, Inc. Quarterly Income Tax Expense (Benefit) in USD from Q2 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Innoviva, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2013 to Q3 2024.
  • Innoviva, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $5.64M, a 44.3% increase year-over-year.
  • Innoviva, Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $9.3M, a 49.2% decline year-over-year.
  • Innoviva, Inc. annual Income Tax Expense (Benefit) for 2023 was $14.4M, a 78.4% decline from 2022.
  • Innoviva, Inc. annual Income Tax Expense (Benefit) for 2022 was $66.7M, a 12.8% decline from 2021.
  • Innoviva, Inc. annual Income Tax Expense (Benefit) for 2021 was $76.4M, a 26.5% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $9.3M $5.64M +$1.73M +44.3% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $7.57M -$4.59M -$9.12M -202% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-31
Q1 2024 $16.7M $8.59M +$2.32M +36.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $14.4M -$330K -$3.96M -109% Oct 1, 2023 Dec 31, 2023 10-K/A 2024-03-05
Q3 2023 $18.3M $3.91M -$53.2M -93.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 $71.5M $4.53M +$5.4M Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-31
Q1 2023 $66.1M $6.28M -$585K -8.53% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $66.7M $3.63M -$7.21M -66.5% Oct 1, 2022 Dec 31, 2022 10-K/A 2024-03-05
Q3 2022 $73.9M $57.1M +$36.5M +178% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 $37.4M -$876K -$26.2M -103% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 $63.6M $6.86M -$12.9M -65.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $76.4M $10.8M -$4.9M -31.1% Oct 1, 2021 Dec 31, 2021 10-K/A 2024-03-05
Q3 2021 $81.3M $20.5M +$11.7M +132% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $69.7M $25.3M +$5.44M +27.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-27
Q1 2021 $64.2M $19.7M +$3.8M +23.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $60.4M $15.7M +$3.34M +26.9% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 $57.1M $8.87M -$1.69M -16% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-27
Q2 2020 $58.8M $19.9M +$9.46M +90.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-29
Q1 2020 $49.3M $15.9M +$7.42M +87.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-28
Q4 2019 $41.9M $12.4M +$208M Oct 1, 2019 Dec 31, 2019 10-K 2020-02-19
Q3 2019 -$167M $10.6M +$10.6M Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-28
Q2 2019 -$177M $10.4M +$10.4M Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-29
Q1 2019 -$188M $8.51M +$8.51M Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-29
Q4 2018 -$196M -$196M -$200M -5002% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-19
Q3 2018 $4M $0 $0 Jul 1, 2018 Sep 30, 2018 10-K 2020-02-19
Q2 2018 $4M $0 $0 Apr 1, 2018 Jun 30, 2018 10-K 2020-02-19
Q1 2018 $4M $0 $0 Jan 1, 2018 Mar 31, 2018 10-K 2020-02-19
Q4 2017 $4M $4M Oct 1, 2017 Dec 31, 2017 10-K 2019-02-19
Q3 2017 $0 Jul 1, 2017 Sep 30, 2017 10-K 2019-02-19
Q2 2017 $0 Apr 1, 2017 Jun 30, 2017 10-K 2019-02-19
Q1 2017 $0 Jan 1, 2017 Mar 31, 2017 10-K 2019-02-19
Q3 2015 $0 +$278K Jul 1, 2015 Sep 30, 2015 10-Q 2015-11-05
Q2 2015 $0 -$278K -100% Apr 1, 2015 Jun 30, 2015 10-Q 2015-08-06
Q3 2014 -$278K -$278K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 $278K +$278K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-06
Q3 2013 $0 Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-04
Q2 2013 $0 Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.